5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
US7432289B2 · kind B2 · utility
9Cited by
47References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2002 |
| Grant date | Oct 7, 2008 |
| Priority date | — |
| Expiry date | Oct 16, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I):or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.